A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101
Clinical trial NCT05667129 · COMPLETED
Trial details
- NCT number
- NCT05667129
- Sponsor
- Xeno Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2023-05-30
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.